Business Description
Boryung
ISIN : KR7003850005
Share Class Description:
XKRX:003850: Ordinary SharesCompare
Compare
Traded in other countries / regions
003850.Korea IPO Date
1988-10-24Description
Boryung is part of the healthcare sector. The company's business involves the manufacture and marketing of pharmaceutical products. It manufactures a suite of drugs to address various areas such as blood circulation, gastrointestinal, and hypertension. Boryung markets its products globally through over 100 partners.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.15 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.31 | |||||
| Debt-to-EBITDA | 1.71 | |||||
| Interest Coverage | 7.66 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 3.34 | |||||
| Beneish M-Score | -2.37 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 18.3 | |||||
| 3-Year EBITDA Growth Rate | 21.2 | |||||
| 3-Year EPS without NRI Growth Rate | 16.6 | |||||
| 3-Year Book Growth Rate | 10.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 21.44 | |||||
| Future 3-5Y Total Revenue Growth Rate | 12.9 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.06 | |||||
| 9-Day RSI | 49.49 | |||||
| 14-Day RSI | 48.84 | |||||
| 6-1 Month Momentum % | 6.79 | |||||
| 12-1 Month Momentum % | -14.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | |||||
| Quick Ratio | 0.9 | |||||
| Cash Ratio | 0.11 | |||||
| Days Inventory | 131.82 | |||||
| Days Sales Outstanding | 61.92 | |||||
| Days Payable | 67.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.98 | |||||
| Dividend Payout Ratio | 0.11 | |||||
| 3-Year Dividend Growth Rate | 10.4 | |||||
| 5-Year Yield-on-Cost % | 2.07 | |||||
| 3-Year Average Share Buyback Ratio | -6.1 | |||||
| Shareholder Yield % | 3.93 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 38.1 | |||||
| Operating Margin % | 7.13 | |||||
| Net Margin % | 6.25 | |||||
| FCF Margin % | 5.72 | |||||
| ROE % | 10.87 | |||||
| ROA % | 6.33 | |||||
| ROIC % | 9.78 | |||||
| ROC (Joel Greenblatt) % | 15.83 | |||||
| ROCE % | 9.05 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 10.85 | |||||
| Forward PE Ratio | 10.21 | |||||
| PE Ratio without NRI | 10.96 | |||||
| Price-to-Owner-Earnings | 50.8 | |||||
| PEG Ratio | 0.59 | |||||
| PS Ratio | 0.68 | |||||
| PB Ratio | 1.12 | |||||
| Price-to-Tangible-Book | 1.55 | |||||
| Price-to-Free-Cash-Flow | 11.86 | |||||
| Price-to-Operating-Cash-Flow | 8.42 | |||||
| EV-to-EBIT | 15.42 | |||||
| EV-to-EBITDA | 9.32 | |||||
| EV-to-Revenue | 1.02 | |||||
| EV-to-FCF | 17.89 | |||||
| Price-to-Projected-FCF | 2.44 | |||||
| Price-to-Median-PS-Value | 0.55 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.92 | |||||
| Price-to-Graham-Number | 0.87 | |||||
| Price-to-Net-Current-Asset-Value | 9.81 | |||||
| Earnings Yield (Greenblatt) % | 6.49 | |||||
| FCF Yield % | 6.62 | |||||
| Forward Rate of Return (Yacktman) % | 11.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Boryung Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 991,429.634 | ||
| EPS (TTM) (â‚©) | 941 | ||
| Beta | 0.72 | ||
| Volatility % | 39.8 | ||
| 14-Day RSI | 48.84 | ||
| 14-Day ATR (â‚©) | 361.081931 | ||
| 20-Day SMA (â‚©) | 10109.5 | ||
| 12-1 Month Momentum % | -14.88 | ||
| 52-Week Range (â‚©) | 9180 - 13750 | ||
| Shares Outstanding (Mil) | 83.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Boryung Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Boryung Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Boryung Frequently Asked Questions
What is Boryung(XKRX:003850)'s stock price today?
The current price of XKRX:003850 is â‚©10210.00. The 52 week high of XKRX:003850 is â‚©13750.00 and 52 week low is â‚©9180.00.
When is next earnings date of Boryung(XKRX:003850)?
The next earnings date of Boryung(XKRX:003850) is .
Does Boryung(XKRX:003850) pay dividends? If so, how much?
The Dividend Yield %  of Boryung(XKRX:003850) is 0.98% (As of Today), Highest Dividend Payout Ratio of Boryung(XKRX:003850) was 1.45. The lowest was 0.07. And the median was 0.15. The  Forward Dividend Yield % of Boryung(XKRX:003850) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers